Retatrutide is associated with GLP-1, GIP and glucagon receptor activity
Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro
Board-Certified, Family Medicine TMB License #T3117 NPI: 1821613514 "Weight loss is a medical journey and every patient deserves a physician who walks it with them, not just a subscription that ships a box." Serving 135K+ residents in Midland and patients statewide
Consequently, the subjective experience of food noise aligns with objective neurological changes
Once-weekly formulations (semaglutide, dulaglutide) can be injected morning or night on the same day each week, whilst twice-daily exenatide must be given within 60 minutes before main meals